Evidence supporting the use of: 7,8-Dihydroxyflavone
For the health condition: Neuralgia and Neuritis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

7,8-Dihydroxyflavone (7,8-DHF) is a small molecule that acts as a selective agonist of the TrkB receptor, which is the main receptor for brain-derived neurotrophic factor (BDNF). BDNF-TrkB signaling is crucial for neuronal survival, growth, and synaptic plasticity. Preclinical studies have demonstrated that 7,8-DHF can cross the blood-brain barrier and activate TrkB signaling in the central nervous system, leading to neuroprotective and neuroregenerative effects in various animal models of neural injury and neurodegenerative diseases.

Regarding neuralgia (nerve pain) and neuritis (nerve inflammation), scientific interest in 7,8-DHF is driven by its ability to support neuronal health and promote repair after injury. Animal studies have shown that 7,8-DHF administration can reduce neuropathic pain behaviors and protect against nerve damage in models of chemotherapy-induced peripheral neuropathy and sciatic nerve injury. For example, some studies report reduced mechanical allodynia and improved nerve morphology after 7,8-DHF treatment. These benefits are believed to arise from enhanced neuronal survival, decreased oxidative stress, and suppression of inflammatory responses.

However, there are no robust clinical trials in humans directly evaluating 7,8-DHF for neuralgia or neuritis, and its effects are currently supported only by animal studies and mechanistic rationale. Thus, while the scientific rationale is promising, the evidence is still preliminary and limited to preclinical research, justifying a moderate-low evidence rating.

More about 7,8-Dihydroxyflavone
More about Neuralgia and Neuritis

Products containing 7,8-Dihydroxyflavone

We currently have no products on Vitabase that contain this ingredient.